PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Antifungals and psilocybin.

7 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

7Records
0With human data

Also searched as antifungal

01 What the evidence covers

Best evidence available per medication
7No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Fluconazole · DiflucanEvidence: No psilocybin data

    Vaginal yeast infection (vaginal candidiasis); Mouth, throat and esophageal yeast infections (candidiasis)

    It may slow how the body clears psilocybin, raising levels. Also, it can cause heart-rhythm (QT) effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Itraconazole · Sporanox, TolsuraEvidence: No psilocybin data

    Blastomycosis; Histoplasmosis

    It may slow how the body clears psilocybin by blocking a minor clearing enzyme. Also, its label warns of heart failure and heart-rhythm (QT) effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ketoconazole · NizoralEvidence: No psilocybin data

    Serious fungal infections (blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, paracoccidioidomycosis) when other treatments fail; Ringworm, jock itch, and athlete's foot (tinea)

    As tablets, it may slow how the body clears psilocybin; creams are barely absorbed. Also, tablets can cause liver injury and heart-rhythm (QT) effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Levoketoconazole · RecorlevEvidence: No psilocybin data

    Endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or has not been curative

    It may slow how the body clears psilocybin (not studied with psilocybin). Also, it can cause liver injury, heart-rhythm (QT) effects and low cortisol.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Posaconazole · NoxafilEvidence: No psilocybin data

    Invasive aspergillosis (treatment); Prevention of invasive Aspergillus and Candida infections in severely immunocompromised people

    Not studied with psilocybin; it slows an enzyme that helps break down psilocybin, so higher levels are possible. Also, it can cause heart-rhythm (QT) effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Terbinafine (oral) · LamisilEvidence: No psilocybin data

    Fungal nail infection (onychomycosis)

    It strongly blocks one enzyme that breaks down psilocybin; gene differences in that enzyme did not change levels in people.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Voriconazole · VfendEvidence: No psilocybin data

    Invasive aspergillosis; Candidemia and deep tissue Candida infections

    Not studied with psilocybin; it blocks an enzyme that clears psilocybin, so higher levels are possible. Also, it can affect heart rhythm and cause hallucinations.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
7Liver injury
6QT-prolonging

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
7Thomann J, Kolaczynska KE, Stoeckmann OV, et al. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin. Front Pharmacol 2024;15:1391689.
3Manevski N, Kurkela M, Höglund C, et al. Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos 2010;38(3):386–395.

Records reviewed 2026-10-03 to 2026-10-04. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25